Phillips Wealth Planners LLC purchased a new position in Genpact Limited (NYSE:G – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,647 shares of the business services provider’s stock, valued at approximately $201,000.
Other hedge funds have also made changes to their positions in the company. Jensen Investment Management Inc. raised its position in Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider’s stock valued at $7,449,000 after acquiring an additional 11,410 shares in the last quarter. Stifel Financial Corp bought a new position in Genpact during the third quarter valued at approximately $1,197,000. Burney Co. raised its position in Genpact by 242.8% during the fourth quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock valued at $5,618,000 after acquiring an additional 92,641 shares in the last quarter. JPMorgan Chase & Co. raised its position in Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after acquiring an additional 2,060,595 shares in the last quarter. Finally, HighTower Advisors LLC bought a new position in Genpact during the third quarter valued at approximately $232,000. 96.03% of the stock is owned by hedge funds and other institutional investors.
Genpact Trading Down 0.8 %
Shares of Genpact stock opened at $45.79 on Thursday. The company’s fifty day simple moving average is $44.39 and its 200-day simple moving average is $40.02. The company has a market cap of $8.08 billion, a price-to-earnings ratio of 12.58, a PEG ratio of 1.52 and a beta of 1.18. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 1 year low of $30.23 and a 1 year high of $47.98.
Insiders Place Their Bets
In other news, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares of the company’s stock, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 35,058 shares of company stock worth $1,558,675 over the last 90 days. Corporate insiders own 2.80% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on the stock. TD Cowen raised their price objective on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research report on Friday, November 8th. Robert W. Baird raised their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and lifted their price target for the company from $44.00 to $55.00 in a research report on Tuesday. Finally, Needham & Company LLC lifted their price target on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, November 11th. Seven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Genpact has a consensus rating of “Hold” and a consensus target price of $44.00.
View Our Latest Research Report on G
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
- Five stocks we like better than Genpact
- How to Read Stock Charts for Beginners
- Oracle Announces Game-Changing News for the AI Industry
- How to Plot Fibonacci Price Inflection Levels
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What is diluted earnings per share (Diluted EPS)?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.